# US 2024/0199691 A1 · Expression and purification of cas enzymes

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0199691 A1
- Document ID: US20240199691A1
- Status: Published application
- Kind: A1
- Application number: 18/416,017
- Filed: 2024-01-18
- Published: 2024-06-20
- Earliest claimed: 2020-02-27
- Assignees: Integrated Dna Technologies, Inc.
- Applicants: Integrated Dna Technologies, Inc.
- Inventors: Sarah Franz BEAUDOIN; Michael Allen COLLINGWOOD; Christopher Anthony VAKULSKAS; Mark Aaron BEHLKE
- Web page: https://patentgrep.com/patent/US20240199691A1

## CPC

- C07K 1/36: by a combination of two or more processes of different types
- C07K 1/18: Ion-exchange chromatography
- C07K 1/22: Affinity chromatography or related techniques based upon selective absorption processes
- C12N 9/226: {Class 2 CAS enzyme complex, e.g. single CAS protein}
- C12Y 301/00: Hydrolases acting on ester bonds (3.1)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES

## Abstract

Described herein are methods for the expression and purification of Cas13a and methods for detecting target RNA using Cas13a.

## Claims

### Claim 1

A method for expressing and purifying a Cas13a protein, the method comprising:
(a) inserting a nucleotide sequence encoding a polypeptide having the polypeptide sequence of SEQ ID NO: 2 or 4 into an expression plasmid;
(b) transforming one or more cells with the expression plasmid;
(c) inducing expression of the transformed plasmid;
(d) isolating the cells;
(e) extracting the Cas13a protein; and
(f) purifying the protein using affinity purification and ion exchange purification.

### Claim 2 (depends on 1)

The method of claim 1, wherein the cell comprises E. coli BL21(DE3).

### Claim 3 (depends on 1)

The method of claim 1, wherein the expression plasmid comprises pET28 or pET28-MBP-TEV plasmids.

### Claim 4 (depends on 1)

The method of claim 1, wherein the nucleotide sequence is inserted into the expression plasmid using isothermal assembly.

### Claim 6 (depends on 1)

The method of claim 1, wherein the affinity purification comprises a nickel or a maltose affinity media.

### Claim 7 (depends on 1)

The method of claim 1, wherein the affinity purification comprises affinity chromatography comprising:
(f)(1) equilibrating a nickel affinity column with a binding buffer and loading the extracted Cas13a protein;
(f)(2) washing the nickel affinity column with a wash buffer; and
(f)(3) eluting the affinity purified Cas13a protein from the nickel affinity column using an elution buffer.

### Claim 8 (depends on 1)

The method of claim 1, wherein the affinity purification comprises affinity chromatography comprising:
(f)(1) equilibrating a maltose affinity column with a binding buffer and loading the extracted Cas13a protein;
(f)(2) washing the maltose affinity column with a wash buffer; and
(f)(3) eluting the affinity purified Cas13a protein from the maltose affinity column using an elution buffer.

### Claim 9 (depends on 1)

The method of claim 1, wherein the ion exchange purification comprises a cation exchange media.

### Claim 10 (depends on 1)

The method of claim 1, wherein the ion exchange purification comprises cation exchange chromatography comprising:
(f)(1) equilibrating a cation exchange column with a binding buffer and loading the extracted Cas13a protein;
(f)(2) washing the cation exchange column with a wash buffer; and
(f)(3) eluting the cation exchange purified Cas13a protein from the cation exchange column using an elution buffer.

### Claim 11 (depends on 1)

The method of claim 1, further comprising concentrating the purified Cas13a protein to approximately 10 mg/mL.

### Claim 12 (depends on 11)

The method of claim 11, further comprising dialyzing the concentrated purified Cas13a protein.

### Claim 13

A method for purifying a recombinant Cas13a protein, the method comprising:
(a) providing an expressed recombinant Cas13a protein having the polypeptide sequence of SEQ ID NO: 2 or 4;
(b) performing an affinity purification comprising a nickel affinity media or a maltose affinity media;
(c) performing an ion exchange purification comprising a cation exchange media; and
(d) collecting the purified Cas13a protein.

### Claim 14 (depends on 13)

The method of claim 13, further comprising concentrating the purified Cas13a protein to approximately 10 mg/mL.

### Claim 15 (depends on 14)

The method of claim 14, further comprising dialyzing the concentrated purified Cas13a protein against three rounds of dialysis buffer.
